SE8701934D0 - Enhanced expression of human interleukin-2 in mammalian cells - Google Patents

Enhanced expression of human interleukin-2 in mammalian cells

Info

Publication number
SE8701934D0
SE8701934D0 SE8701934A SE8701934A SE8701934D0 SE 8701934 D0 SE8701934 D0 SE 8701934D0 SE 8701934 A SE8701934 A SE 8701934A SE 8701934 A SE8701934 A SE 8701934A SE 8701934 D0 SE8701934 D0 SE 8701934D0
Authority
SE
Sweden
Prior art keywords
mammalian cells
human interleukin
enhanced expression
interleukin
high level
Prior art date
Application number
SE8701934A
Other languages
English (en)
Other versions
SE8701934L (sv
Inventor
B R Cullen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE8701934D0 publication Critical patent/SE8701934D0/sv
Publication of SE8701934L publication Critical patent/SE8701934L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
SE8701934A 1986-05-12 1987-05-11 Okad expression av humant interleukin-2 i deggdjursceller SE8701934L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/862,082 US4992367A (en) 1986-05-12 1986-05-12 Enhanced expression of human interleukin-2 in mammalian cells

Publications (2)

Publication Number Publication Date
SE8701934D0 true SE8701934D0 (sv) 1987-05-11
SE8701934L SE8701934L (sv) 1987-11-13

Family

ID=25337602

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8701934A SE8701934L (sv) 1986-05-12 1987-05-11 Okad expression av humant interleukin-2 i deggdjursceller

Country Status (25)

Country Link
US (1) US4992367A (sv)
JP (1) JPS62278994A (sv)
AR (1) AR241794A1 (sv)
AT (1) AT389892B (sv)
AU (1) AU603576B2 (sv)
BE (1) BE1000717A5 (sv)
CH (1) CH675731A5 (sv)
DE (1) DE3715808A1 (sv)
DK (1) DK234087A (sv)
ES (2) ES2006476A6 (sv)
FI (1) FI872096A (sv)
FR (1) FR2598433B1 (sv)
GB (1) GB2190382B (sv)
GR (1) GR870727B (sv)
HU (1) HU205384B (sv)
IL (1) IL82475A0 (sv)
IT (1) IT1215478B (sv)
LU (1) LU86874A1 (sv)
MC (1) MC1821A1 (sv)
NL (1) NL8701132A (sv)
NO (1) NO871939L (sv)
NZ (1) NZ220246A (sv)
PT (1) PT84849B (sv)
SE (1) SE8701934L (sv)
ZA (1) ZA872768B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0138654B1 (ko) * 1987-08-26 1998-04-30 프레드릭 에이. 유스티스, 3세 인터루킨-i 저해제 및 이의 제조방법
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
FR2636231A1 (fr) * 1988-09-09 1990-03-16 Sanofi Sa Cellules eucaryotes recombinees productrices d'interleukine-1 (beta) mature n-glycosylee, procede et vecteurs necessaires pour leur obtention et procede d'obtention d'interleukine-1 (beta) mature n-glycosylee
WO1990010069A1 (en) * 1989-02-28 1990-09-07 Institut Organicheskogo Sinteza Akademii Nauk Latviiskoi Ssr RECOMBINANT PLASMID DNA pAA 1213-23 AND pAC 262-33 CODING FOR SYNTHESIS OF HUMAN INTERLEUKIN-2, METHOD OF THEIR CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI RRI/pAC 262-33 AS PRODUCER OF HUMAN INTERLEUKIN-2
IL95330A0 (en) * 1989-08-11 1991-06-30 Lilly Co Eli Expression of a functional insect specific toxin gene in mammalian cells
GB9106185D0 (en) * 1991-03-22 1991-05-08 Wellcome Found Biological control agents
US5548075A (en) * 1993-08-30 1996-08-20 Utah State University DNA cassette and transgenic organisms carrying lytic peptide-encoding genes
US5856178A (en) * 1993-08-30 1999-01-05 Utah State University DNA cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same
US5641665A (en) * 1994-11-28 1997-06-24 Vical Incorporated Plasmids suitable for IL-2 expression
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
EP0855918A4 (en) 1995-10-17 2002-08-14 Univ Wayne State INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF
US6001613A (en) * 1996-05-24 1999-12-14 Board Of Regents Of University Of Nebraska Plasmid bearing a cDNA copy of the genome of bovine viral diarrhea virus, chimeric derivatives thereof, and method of producing an infectious bovine viral diarrhea virus using said plasmid
AUPP655698A0 (en) 1998-10-16 1998-11-05 Commonwealth Scientific And Industrial Research Organisation Delivery system for porcine somatotropin
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
KR20020043448A (ko) * 2000-12-04 2002-06-10 리송알렉스인근 인터루킨-2 재조합 단백질 및 그의 제조방법
US20040071671A1 (en) * 2001-02-20 2004-04-15 Leturcq Didier J. Cell therapy method for the treatment of tumors
EA013944B1 (ru) * 2001-02-20 2010-08-30 Орто-Макнейл Фармасьютикал, Инк. Способ получения неприродной антигенпрезентирующей клеточной линии и применение линии для лечения опухолей

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814039C3 (de) * 1978-03-31 1981-02-19 Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig Verfahren zur Herstellung von Hybrid-Bakterien
US4405712A (en) * 1981-07-01 1983-09-20 The United States Of America As Represented By The Department Of Health And Human Services LTR-Vectors
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
AU556353B2 (en) * 1982-12-15 1986-10-30 Ajinomoto Co., Inc. Interleukin-2 polypeptide
AU579089B2 (en) * 1983-02-08 1988-11-17 Biogen, Inc. Human interleukin-2-like polypeptides
EP0119621A1 (en) * 1983-03-21 1984-09-26 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Interleukin-2
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
GB8327880D0 (en) * 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
JPS61500586A (ja) * 1983-11-14 1986-04-03 チロン　コ−ポレイシヨン インタ−ロイキン−２産生のための方法及び組成物
FR2559782B1 (fr) * 1984-02-16 1986-07-18 Transgene Sa Vecteur d'expression dans les levures de l'interleukine-2, levures transformees et procede de preparation de l'interleukine-2
DE3574731D1 (de) * 1984-05-08 1990-01-18 Genetics Inst Ein menschlicher t-zellwachstumsfaktor.
DE3419995A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
EP0172619A1 (en) * 1984-06-20 1986-02-26 Takeda Chemical Industries, Ltd. Novel transformant and use thereof
CA1275954C (en) * 1984-08-31 1990-11-06 Hing Cheug Wong 3'-expression enhancing fragments and method
FR2583770B1 (fr) * 1985-06-21 1988-08-19 Transgene Sa Expression de l'il-2 humaine dans les cellules de mammiferes par un poxvirus recombine
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices

Also Published As

Publication number Publication date
DE3715808A1 (de) 1987-12-10
AU7270387A (en) 1987-11-19
JPS62278994A (ja) 1987-12-03
BE1000717A5 (fr) 1989-03-21
ATA263787A (de) 1989-07-15
FI872096A0 (fi) 1987-05-12
FR2598433A1 (fr) 1987-11-13
NO871939D0 (no) 1987-05-11
PT84849B (pt) 1990-02-08
CH675731A5 (sv) 1990-10-31
GB2190382B (en) 1990-08-15
HU205384B (en) 1992-04-28
DK234087A (da) 1987-11-13
NO871939L (no) 1987-11-13
FR2598433B1 (fr) 1990-09-21
AU603576B2 (en) 1990-11-22
HUT45558A (en) 1988-07-28
US4992367A (en) 1991-02-12
FI872096A (fi) 1987-11-13
MC1821A1 (fr) 1988-03-18
GB2190382A (en) 1987-11-18
NZ220246A (en) 1990-07-26
AT389892B (de) 1990-02-12
IL82475A0 (en) 1987-11-30
GB8711072D0 (en) 1987-06-17
NL8701132A (nl) 1987-12-01
SE8701934L (sv) 1987-11-13
GR870727B (en) 1987-09-21
IT1215478B (it) 1990-02-14
PT84849A (pt) 1987-06-01
ES2006476A6 (es) 1989-05-01
LU86874A1 (fr) 1988-06-13
DK234087D0 (da) 1987-05-08
ZA872768B (en) 1988-04-27
ES2012940A6 (es) 1990-04-16
AR241794A1 (es) 1992-12-30
IT8720479A0 (it) 1987-05-12

Similar Documents

Publication Publication Date Title
SE8701934D0 (sv) Enhanced expression of human interleukin-2 in mammalian cells
NO890587D0 (no) Nye proteiner med faktor viii aktivitet: fremgangsmaate for fremstilling derav ved anvendelse av genetisk omkonstruerte celler og farmasoeytiske sammensetninger som inneholder disse.
MY102029A (en) Human factor viii, compositions containing it, methods and materials for use in its production
ATE277078T1 (de) N-terminal modifizierte polypeptide, und herstellungsprozess
FI19992064A (sv) Förfarande för framställning av erythropoietin
EP0192392A3 (en) Insulin receptor, its purification, its production in recombinant cells, dna therefor, antibodies to insulin receptor and their preparation, and pharmaceutical compositions containing them
ES8505405A1 (es) Un procedimiento para producir un activador de plasminogeno purificado.
DK513385A (da) Polypeptid, fremgangsmaade til dets fremstilling og farmaceutisk praeparat indeholdende et saadant polypeptid
IL74947A (en) Analogs of human gamma interferon having the partial sequence of human gamma interferon and genetic engineering process for the preparation thereof
EP0286441A3 (en) Novel cytotoxic protein
ES2068913T3 (es) Peptolidos que contienen acido pipecolico, su preparacion y composiciones farmaceuticas que los contienen.
GB8827592D0 (en) Improvements in & relating to regulation of expression
KR880009127A (ko) 용성 성숙 hIL-β 및 변경된 생물학적 활성을 갖는 유도체를 이 콜라이에서 고도로 발현시키는 플라즈미드 및 그 방법
ATE123056T1 (de) Ancrod-proteine, ihre herstellung und verwendung.
ATE108207T1 (de) Polypeptide und dafür kodierende dna.
FI895183A0 (fi) Foerfarande foer selektiv spjaelkning av fusionsproteiner.
EP0386240A4 (en) Novel polypeptide compounds
ATE141104T1 (de) Gentechnische herstellung von protein pp 15.
MX9605986A (es) Analogos sinteticos de peptidos de la proteina de la superficie pulmonar sp-c.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8701934-5

Effective date: 19930319